Licensing of medicines is the responsibility of the Medicines and Healthcare products Regulatory Agency (MHRA) and is reserved to the UK government. The senior naloxone co-ordinator, has been in regular discussion with the MHRA to discuss the possibility of licensing an “off-the-shelf” naloxone kit.